Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fully synthetic self-adjuvanting MUC1-fibroblast stimulating lipopeptide 1 conjugates as potential cancer vaccines
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 52, Issue 72, Pages 10886-10889
Publisher
Royal Society of Chemistry (RSC)
Online
2016-08-04
DOI
10.1039/c6cc04623a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer
- (2016) Björn Palitzsch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment
- (2016) Nuria Martínez-Sáez et al. Chemical Science
- Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide
- (2015) Pamela Thompson et al. CHEMICAL COMMUNICATIONS
- A fully synthetic self-adjuvanting globo H-Based vaccine elicited strong T cell-mediated antitumor immunity
- (2015) Zhifang Zhou et al. Chemical Science
- A Cancer Therapeutic Vaccine based on Clustered Tn-Antigen Mimetics Induces Strong Antibody-Mediated Protective Immunity
- (2014) Barbara Richichi et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthetic Multivalent Glycopeptide-Lipopeptide Antitumor Vaccines: Impact of the Cluster Effect on the Killing of Tumor Cells
- (2014) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Fully Synthetic Four-Component Antitumor Vaccine Consisting of a Mucin Glycopeptide Antigen Combined with Three Different T-Helper-Cell Epitopes
- (2014) Björn Palitzsch et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis and immunological evaluation of self-adjuvanting MUC1-macrophage activating lipopeptide 2 conjugate vaccine candidates
- (2014) David M. McDonald et al. CHEMICAL COMMUNICATIONS
- Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers
- (2014) Zhifang Zhou et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CpG-Loaded Multifunctional Cationic Nanohydrogel Particles as Self-Adjuvanting Glycopeptide Antitumor Vaccines
- (2014) Sebastian Hartmann et al. Advanced Healthcare Materials
- Water-Soluble Polymers Coupled with Glycopeptide Antigens and T-Cell Epitopes as Potential Antitumor Vaccines
- (2013) Lutz Nuhn et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid
- (2013) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The development of synthetic antitumour vaccines from mucin glycopeptide antigens
- (2013) Nikola Gaidzik et al. CHEMICAL SOCIETY REVIEWS
- Synthetically defined glycoprotein vaccines: current status and future directions
- (2013) Roberto Adamo et al. Chemical Science
- Variation of the Glycosylation Pattern in MUC1 Glycopeptide BSA Vaccines and Its Influence on the Immune Response
- (2012) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tobacco Mosaic Virus as a New Carrier for Tumor Associated Carbohydrate Antigens
- (2012) Zhaojun Yin et al. BIOCONJUGATE CHEMISTRY
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Self-Adjuvanting Multicomponent Cancer Vaccine Candidates Combining Per-Glycosylated MUC1 Glycopeptides and the Toll-like Receptor 2 Agonist Pam3CysSer
- (2011) Brendan L. Wilkinson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues
- (2011) Nikola Gaidzik et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- In vivo anti- and pro-tumour activities of the TLR2 ligand FSL-1
- (2011) Kazuto Kiura et al. IMMUNOBIOLOGY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fully Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll-like Receptor 2
- (2010) Anton Kaiser et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
- (2010) Mariusz Skwarczynski et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Synthesis of MUC1–lipopeptide chimeras
- (2010) Brendan L. Wilkinson et al. CHEMICAL COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search